Gaber, M., Bakheet, R., Mahmoud, F. (2017). RISK FACTORS OF CANCER AND HOW TO PREVENT. test, 21(2), 179-183. doi: 10.21608/smj.2017.41298
Mohmed Gaber; Raafat Abd El-aal Bakheet; Fatma Ibrahim Mahmoud. "RISK FACTORS OF CANCER AND HOW TO PREVENT". test, 21, 2, 2017, 179-183. doi: 10.21608/smj.2017.41298
Gaber, M., Bakheet, R., Mahmoud, F. (2017). 'RISK FACTORS OF CANCER AND HOW TO PREVENT', test, 21(2), pp. 179-183. doi: 10.21608/smj.2017.41298
Gaber, M., Bakheet, R., Mahmoud, F. RISK FACTORS OF CANCER AND HOW TO PREVENT. test, 2017; 21(2): 179-183. doi: 10.21608/smj.2017.41298

RISK FACTORS OF CANCER AND HOW TO PREVENT

Sohag Medical Journal
Article 20, Volume 21, Issue 2, July 2017, Pages 179-183    PDF (57.73 K)
Document Type: Original Article
DOI: 10.21608/smj.2017.41298
Authors
Mohmed Gaber1; Raafat Abd El-aal Bakheet2; Fatma Ibrahim Mahmoud3
1Department of Clinical Oncology ,Faculty of Medicine,Sohag University.
2DEPARTMENT of CLINICAL ONCOLOGY .SOHAG FACULTY OF MEDICINE.SOHAG UNIVERSITY.EGYPT
3DEPARTMENT of CLINICAL ONCOLOGY.SOHAG FACULTY OF MEDICINE.SOHAG UNIVERSITY.EGYPT.
Abstract
Cancers are a large family of diseases which involve abnormal cell growth with the potential to invade or spread to other parts of the body. They form a subset of neoplasms. The aim of the work to show the magnitude of the problem of cancer, The possible etiologic causes of cancer in general as the great majority of cancers, are due to environmental factors. The remaining are due to inherited genetics. Common environmental factors that contribute to cancer death include tobacco (25–30%), diet and obesity (30–35%), infections (15–20%), radiation (both ionizing and non-ionizing, up to 10%), stress, lack of physical activity, and environmental pollutants. How to early detect cancer and Screening of the general population. Preventive measures applied certain types of cancer such as diet,medications,vitamins and vaccines.
Supplementary Files
References
  1. Cancer Fact sheet N°297". World Health Organization. February 2014. Retrieved 10 June 2014. 
  2. Vainio H, Bianchini F, eds. Weight control and physical activity, vol. 6. IARC Handbooks of Cancer Prevention. Lyon, France: IARC Press, 2000.
  3. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 83. Lyon, France: IARC, 2004:1179.
  4. Sung, Max W; Thung, Swan N; Acs, George (2000). "Hepatitis Viruses". In Bast RC, Kufe DW, Pollock RE, et al. Holland-Frei Cancer Medicine (5th ed.). Hamilton, Ontario: B.C. Decker. ISBN 1-55009-113-1
  5. McLachlin, Catherine M; Crum, Christopher P (2000). "Papillomaviruses and Cervical Neoplasia". In Bast RC, Kufe DW, Pollock RE, et al. Holland-Frei Cancer Medicine (e.5 ed.). Hamilton, Ontario: B.C. Decker. ISBN 1-55009-113-1.
  6. Smith EC (2012). "An overview of hereditary breast and ovarian cancer syndrome". J Midwifery Womens Health 57 (6): 577–84. doi:10.1111/j.1542-2011.2012.00199.x. PMID 23050669.
  7. Macrae F, du Sart D, Nasioulas S (2009). "Familial adenomatous polyposis". Best Pract Res Clin Gastroenterol 23 (2): 197–207. doi:10.1016/j.bpg.2009.02.010. PMID 19414146.
  8. U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014
  9. Guillem JG, Wood WC, Moley JF, et al. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol 2006;24:4642–4660.
  10. Domchek SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010;304:967–975.
  11. Greenwald P, Kelloff G. The role of chemoprevention in cancer control. IARC Scientific Publications (Lyon) 1996;139:13–22.
  12. McCullough M, Robertson AS, Rodriguez C, et al. Calcium, vitamin D, dairy products, and risk of colorectal cancer in the cancer prevention study II nutrition cohort (United States). Cancer Causes Control 2003;14:1–12.
  13. Fisher B, Redmond C. New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent. J Natl Cancer Inst 1991;83:1278–1280.
  14. Thompson IM Jr, Goodman PJ, Tangen CM, et al. Long-term survival of participants in the prostate cancer prevention trial. N Engl J Med 2013;369:603–610.
  15. Shapiro S. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan. J Natl Cancer Inst Monogr 1997:27–30.
  16. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012;366:2345–2357.
  17. Brierley KL, Blouch E, Cogswell W, et al. Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications.cancer J 2012,18:303-309.
  18. Lollini PL, Cavallo F, Nanni P, Forni G. Vaccines for tumour prevention. Nature Reviews Cancer 2006; 6(3):204–216. [PubMed Abstract]
  19. Anand P, Kunnumakkara AB, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB (September 2008). "Cancer is a preventable disease that requires major lifestyle changes". Pharm. Res. 25 (9): 2097–116. doi:10.1007/s11095-008-9661-9. PMC 2515569. PMID 18626751.
Statistics
Article View: 218
PDF Download: 220